Targetting cancer with Ru(III/II)-phosphodiesterase inhibitor adducts: A novel approach in the treatment of cancer
Author:
Funder
Department of Biotechnology (DBT)
Govt. of India
Publisher
Elsevier BV
Subject
General Medicine
Reference62 articles.
1. Platinum compounds: a new class of potent antitumour agents;Rosenberg;Nature,1969
2. Bioorganometallic chemistry – from teaching paradigms to medicinal applications;Hartinger;Chem Soc Rev,2009
3. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects;Florea;Cancers,2011
4. In vivo cisplatin-DNA adducts formation and removals as measured with immunochemical techniques;Fichtinger-Schepman,1988
5. An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts;Szymkowski;Proc Natl Acad Sci USA,1992
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unveiling the anticancer activity of ruthenium and iron complexes;Inorganic Chemistry Communications;2024-07
2. Repurposing PDE5 inhibitor tadalafil and sildenafil as anticancer agent against hepatocellular carcinoma via targeting key events of glucose metabolism and multidrug resistance;Journal of Biochemical and Molecular Toxicology;2022-05-24
3. Ruthenium Complexes as Promising Candidates against Lung Cancer;Molecules;2021-07-21
4. Nanoparticles weaponized with built‐in functions for imaging‐guided cancer therapy;View;2020-05-20
5. Diprophylline inhibits non‑small cell lung cancer A549 cell proliferation and migration, and promotes apoptosis, by downregulating PI3K signaling pathway;Oncology Letters;2018-11-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3